✦ LIBER ✦

P347 Benefit of denosumab therapy in patients with bone metastases from breast cancer: A number-needed-to-treat (NNT) analysis

✍ Scribed by M. Martin; G. Steger; R. von Moos; A. Stopeck; R. de Boer; H. Bourgeois; K. Inoue; B. Ding; K. Chung; A. Braun

Book ID: 114316680
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 35 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(11)70283-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

176 NUMBER NEEDED TO TREAT AND RISK BENE

176 NUMBER NEEDED TO TREAT AND RISK BENEFIT ANALYSIS OF DENOSUMAB VERSUS ZOLEDRONIC ACID IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES

✍ Xie, Jipan; Diener, Melissa; Wu, Eric; Sorg, Rachael; Yu, Andrew; Namjoshi, Madh 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

PCN21 NUMBER NEEDED TO TREAT (NNT) ANALY

PCN21 NUMBER NEEDED TO TREAT (NNT) ANALYSIS COMPARING BENEFITS OF LETROZOLE WITH ADJUVANT CHEMOTHERAPY IN PATIENTS WITH NODE-POSITIVE BREAST CANCER

✍ N Dhillon; S Kaura; G Dranitsaris; H Rugo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

P106 A Number-Needed-to-Treat(NNT) analy

P106 A Number-Needed-to-Treat(NNT) analysis of bonerelapse and mortality in a randomized trial of oral clodronate as supplementary adjuvant therapy for operable breast cancer

✍ T. Powles; A. Paterson; E. McCloskey; J. Kanis 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 162 KB

P170 The number needed to treat (NNT) as

P170 The number needed to treat (NNT) as a measure of drug efficacy: the case of aromatase inhibitors (AIs) in post menopausal women with early breast cancer

✍ H. Rugo; S. Kaura; G. Dranitsaris 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 43 KB

3603 POSTER The Number Needed to Treat (

3603 POSTER The Number Needed to Treat (NNT) as a Measure of Incremental Drug Benefit: Denosumab Vs. Zoledronic Acid for the Prevention of Skeletal Related Events (SREs) in Patients With Other Solid Tumours or Multiple Myeloma

✍ G. Dranitsaris; S. Kaura 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

P.061 Modeling clinical benefits of supp

P.061 Modeling clinical benefits of suppressing viral replication in HBeAg-negative chronic hepatitis B (CHB) patients: a number-needed-to-treat (NNT) analysis of entecavir and adefovir

✍ U. Iloeje; Y. Yuan; K. Klesczewski; J. Hay 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB